Sugadapa Tablets

Adult dosage

This medication can be administered to patients receiving evogliptin 5 mg and dapagliflozin 10 mg, regardless of meal timing, with a dosage of 1 tablet once daily (as 5 mg/10 mg evogliptin/dapagliflozin).

This medication should not be administered to certain patients. For example, individuals allergic to this drug's active ingredients or excipients, patients with type 1 diabetes, those with diabetic ketoacidosis, and patients undergoing dialysis should not use this medication as it may pose risks. Patients with heart failure or impaired kidney function, as well as those with reduced fluid volume, should exercise caution when taking this medication. It is particularly not recommended for patients with severe heart failure, and those with reduced kidney function may experience elevated drug concentrations, requiring close monitoring of their condition. This medication is not recommended for patients with severely impaired liver function, and if there is a history of acute pancreatitis or symptoms suggestive of pancreatitis, the medication should be discontinued immediately and a physician consulted. Various adverse reactions may occur when taking this medication, including dyspepsia, infections, arthralgia, headache, dizziness, and skin rashes. Hypoglycemic symptoms may also arise, necessitating caution. One of the active ingredients, dapagliflozin, carries risks of genital infections, urinary tract infections, fluid volume depletion, and ketoacidosis; therefore, if symptoms of infection or dehydration appear, medical staff should be informed immediately. While this medication interacts minimally with other medications, the concentration may change when taken with some antibiotics or antituberculosis drugs, so it is advisable to consult with a physician or pharmacist. Pregnant or breastfeeding women are advised against using this medication, and use should be discontinued upon confirmation of pregnancy. Elderly patients may have reduced kidney or liver function, thus their condition should be closely monitored when taking this medication. In cases of overdose, there is no specific antidote; appropriate treatment should be administered based on symptoms and the medication should be stored out of reach of children.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reaction, severe rash with fever, blisters, peeling skin, pain in mucous membranes (mouth/eyes), severe skin reactions, shortness of breath or difficulty breathing, asthma attack, respiratory issues accompanying cough and fever, respiratory problems, jaundice (yellowing of skin or eyes), profound lethargy, liver abnormalities (jaundice), sudden and

Mild side effects

• Dyspepsia
• constipation
• chronic gastritis
• colon polyps
• gastric ulcer
• gastroesophageal reflux disease
• hemorrhoids
• vaginal infections
• herpes zoster
• cystitis

This medication should be stored in a tightly closed container to avoid exposure to air and moisture. The recommended storage temperature is room temperature between 1 and 30 degrees Celsius.

Appearance

Pale pink round film-coated tablet

Package unit

PTP (Alu-Alu) - 30 tablets/box [(10 tablets/PTP x 3)]